Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Thompson S, Cioffi-Lavina M, Chapman-Fredricks J, Gomez-Fernandez C, Fernandez-Castro G, Jorda M.
Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):395-9.
Related citations
Adenocarcinoma of the urinary bladder.
Roy S, Parwani AV.
Arch Pathol Lab Med. 2011 Dec;135(12):1601-5. Review.
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
Hua MY, Yang HW, Liu HL, Tsai RY, Pang ST, Chuang KL, Chang YS, Hwang TL, Chang YH, Chuang HC, Chuang CK.
Biomaterials. 2011 Dec;32(34):8999-9010. Epub 2011 Aug 27.
Transitional cell carcinoma of the urinary bladder in a 14-year-old dog.
Caswell M.
Can Vet J. 2011 Jun;52(6):673-5.
MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.
Chen H, Lin YW, Mao YQ, Wu J, Liu YF, Zheng XY, Xie LP.
Cancer Lett. 2012 Jul 1;320(1):40-7. Epub 2012 Jan 20.
Discrimination of agonist and antagonist forms of CXCL10 in biological samples.
Casrouge A, Bisiaux A, Stephen L, Schmolz M, Mapes J, Pfister C, Pol S, Mallet V, Albert ML.
Clin Exp Immunol. 2012 Jan;167(1):137-48. doi: 10.1111/j.1365-2249.2011.04488.x.
Cucurbitacin E Induces G(2)/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells.
Huang WW, Yang JS, Lin MW, Chen PY, Chiou SM, Chueh FS, Lan YH, Pai SJ, Tsuzuki M, Ho WJ, Chung JG.
Evid Based Complement Alternat Med. 2012;2012:952762. Epub 2012 Jan 9.
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
Fei X, Qi M, Wu B, Song Y, Wang Y, Li T.
FEBS Lett. 2012 Feb 17;586(4):392-7. Epub 2012 Jan 16.
Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.
Feng CC, Wang PH, Guan M, Jiang HW, Wen H, Ding Q, Wu Z.
Folia Biol (Praha). 2011;57(6):242-7.
[Local recurrence of micropapillary bladder tumor after radical cystectomy : successful treatment with radiation therapy : a case report].
Suzuki K, Shimada T, Ebine T, Momma T.
Hinyokika Kiyo. 2011 Oct;57(10):577-9. Japanese.
[Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer].
Yamada Y, Ueda Y, Higuchi Y, Suzuki T, Maruyama T, Kondoh Y, Nojima M, Noda M, Tomita N, Zozumi M, Hirota S, Yamamoto S.
Hinyokika Kiyo. 2011 Oct;57(10):559-63. Japanese.
[Incidence and risk factors of early postoperative paralytic ileus after radical cystectomy and cutaneous ureterostomy with a unilateral and parallel stoma].
Kim CJ, Sano T, Tomita K, Takimoto K.
Hinyokika Kiyo. 2011 Oct;57(10):535-8. Japanese.
Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk.
Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X.
Int J Cancer. 2012 Jan 19. doi: 10.1002/ijc.27437. [Epub ahead of print]
Urothelial cancers after renal transplantation.
Cox J, Colli JL.
Int Urol Nephrol. 2011 Sep;43(3):681-6. Epub 2011 Mar 4.
Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians.
De Nunzio C, Cicione A, Leonardo F, Rondoni M, Franco G, Cantiani A, Tubaro A, Leonardo C.
Int Urol Nephrol. 2011 Sep;43(3):663-7. Epub 2010 Nov 26.
Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years.
Takenaka A, Hara I, Soga H, Sakai I, Terakawa T, Muramaki M, Miyake H, Tanaka K, Fujisawa M.
Int Urol Nephrol. 2011 Sep;43(3):749-54. Epub 2010 Oct 30.
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T.
J Dermatol. 2011 Oct;38(10):996-8. doi: 10.1111/j.1346-8138.2010.01149.x. Epub 2011 Feb 1. No abstract available.
Characterization of N-cadherin unbinding properties in non-malignant (HCV29) and malignant (T24) bladder cells.
Lekka M, Gil D, Dąbroś W, Jaczewska J, Kulik AJ, Lekki J, Stachura Z, Stachura J, Laidler P.
J Mol Recognit. 2011 Sep-Oct;24(5):833-42. doi: 10.1002/jmr.1123.
Re: Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
Wood DP.
J Urol. 2012 Jan;187(1):352-3. No abstract available.
A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W.
J Urol. 2012 Mar;187(3):1071-9. Epub 2012 Jan 21.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on